Saltar al contenido
Merck

Saltar a

A-166

Adalimumab solution

10.0 mg/mL (12.5 mM Histidine Buffer), certified reference material, Cerilliant®

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
A ustedes/SKUDisponibilidadPrecio
0.25 mL
Comprobar disponibilidad del carrito
$971.000

Acerca de este artículo

Número CAS:
MDL number:
NACRES:
NA.21
UNSPSC Code:
41116107

$971.000


Comprobar disponibilidad del carrito

Solicite una orden a granel
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


grade

certified reference material

Quality Segment

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 0.25 mL

manufacturer/tradename

Cerilliant®

concentration

10.0 mg/mL (12.5 mM Histidine Buffer)

technique(s)

liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

General description

Adalumimab is a therapeutic monoclonal antibody used for the treatment of psoriasis, rheumatoid arthritis, and Crohn′s disease. Adalimumab (Humira) in solution is a primary certified reference material of the recombinantly expressed and purified therapeutic monoclonal antibody (mAb). The product is traceable to higher order standards from National Institute of Standards and Technology (NIST) through an unbroken chain of comparisons. It satisfies the criterion for certified reference material and primary standard categories according to the ISO requirements. The solution contains not less than 0.25 mL of approximately 10 mg/ml certified solution. The manufacturing process follows the quality control standards, ISO 17034, ISO/IEC 17025, and ISO 9001.

Application

Adalimumab (Humira) solution has been used to determine the metrological traceability for adalimumab (ADL). It is also suitable for in vitro applications such as identification, calibration, and quantification of analytes in analytical and R&D settings.

Features and Benefits

  • Adalimumab (Humira) content is quantitatively measured by amino acid analysis (AAA).
  • Every raw material employed has been identified and comprehensively characterized using a variety of analytical methods.
  • The fill volume is gravimetrically verified at various stages during the dispensing process using qualified and calibrated balances.
  • Long-term stability has been evaluated under freezer storage conditions (-10 °C to -25 °C).

Preparation Note

  • Thaw the product in a refrigerator or at room temperature and ensure thorough mixing before use.
  • Avoid refreezing the product once thawed.
  • When spiking into a matrix or diluting to required concentrations, it is recommended to quantitatively transfer the appropriate volume using established laboratory practices.

Other Notes

This product′s purpose is for testing. THIS PRODUCT IS NOT INTENDED FOR HUMAN OR THERAPEUTIC USE. For comprehensive details regarding the nature of any hazards and recommended precautions, kindly refer the safety data sheet.

Legal Information

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
S-1441.09253MSQC11
grade

certified reference material

grade

certified reference material

grade

-

grade

-

format

single component solution

format

multi-component solution

format

-

format

-

concentration

10.0 mg/mL (12.5 mM Histidine Buffer)

concentration

200 μg/mL in methanol ((each analyte))

concentration

-

concentration

-

manufacturer/tradename

Cerilliant®

manufacturer/tradename

Cerilliant®

manufacturer/tradename

-

manufacturer/tradename

-

packaging

ampule of 0.25 mL

packaging

ampule of 1 mL

packaging

-

packaging

vial of 100 μg

feature

Snap-N-Spike®/Snap-N-Shoot®

feature

Snap-N-Spike®/Snap-N-Shoot®

feature

-

feature

-


Clase de almacenamiento

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Questions

1–3 of 3 Questions  
  1. What is the recommended storage condition after diluting the product? How long can it be kept after dilution? 

    1 answer
    1. The recommended storage condition after dilution is influenced by the quality of the solvent used. While specific storage conditions may vary, it is generally advised to store the diluted product at 2-8 °C. The stability of the diluted solution will also depend on the solvent's quality, which can affect how long the product can be kept after dilution.

      Helpful?

  2. What is the extinction coefficient of this CRM?

    1 answer
    1. The extinction coefficient is not determined or reported for this product. Concentration is measured by determining total protein content through quantitative amino acid analysis. Data is provided in the Certificate of Analysis for HPLC-UV-MS analysis, but direct spectrophotometric analysis is not performed.

      Helpful?

  3. What is the approximate concentration of adalimumab (humira) in A-166?

    1 answer
    1. The target concentration of this standard is 10 mg/mL. The actual concentration is reported on the lot-specific Certificate of Analysis. See the link below for a sample COA:
      https://www.cerilliant.com/shopOnline/COA.aspx?itemno=ceebedfd-7433-411d-8f61-5e06225f4e1d&lotno=FN04112201

      Helpful?

Reviews

No rating value

Active Filters